本页面由Tiger Trade Technology Pte. Ltd.提供服务

Achieve Life Sciences, Inc.

7.00
-0.0600-0.85%
盘后:7.000.00000.00%16:31 EDT
成交量:164.60万
成交额:1,152.86万
市值:7.19亿
市盈率:-4.22
高:7.20
开:7.00
低:6.92
收:7.06
52周最高:8.64
52周最低:2.62
股本:1.03亿
流通股本:7,469.04万
量比:1.60
换手率:2.20%
股息:- -
股息率:- -
每股收益(TTM):-1.6600
每股收益(LYR):-1.2535
净资产收益率:-844.99%
总资产收益率:-29.21%
市净率:-48.97
市盈率(LYR):-5.58

数据加载中...

2021/05/13

重要事件披露

8-K - Current report
2021/03/15

重要事件披露

8-K - Current report
2021/03/11

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/11

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/11

重要事件披露

8-K - Current report
2021/02/17

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/30

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/30

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/11/30

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/13

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/12

重要事件披露

8-K - Current report
2020/10/22

重要事件披露

8-K - Current report
2020/10/21

重要事件披露

8-K - Current report
2020/09/30

重要事件披露

8-K - Current report